HFA Premium Access

HELIOS-A: 18month Exploratory Cardiac Results from the Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis

Congress Presentation

About the speaker

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro and CNIC, Madrid (Spain)
48 presentations

4 more presentations in this session

Patiromer for the management of hyperkalemia in subjects receiving renin-angiotensin-aldosterone system inhibitor medications for heart failure with reduced ejection fraction

Speaker: Professor S. Anker (Berlin, DE)


DEFINE-HF and PRESERVED-HF: Dapagliflozin improves heart failure symptoms and physical limitations across the entire range of LVEF

Speaker: Doctor M. Kosiborod (Kansas City, US)


DELIVER baseline and design

Speaker: Professor S. Solomon (Boston, US)


GALACTIC-HF - omecamtiv mecarbil in HFrEF and low blood pressure

Speaker: Professor M. Metra (Brescia, IT)


Access the full session

Late-Breaking Trials - Pharmacological treatment I

Speakers: Doctor P. Garcia-Pavia, Professor S. Anker, Doctor M. Kosiborod, Professor S. Solomon, Professor M. Metra

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb